Moderna
MRNA
#1319
Rank
NZ$23.98 B
Marketcap
$62.17
Share price
3.82%
Change (1 day)
-65.72%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$1.30 Billion

According to Moderna 's latest financial reports the company's total debt is NZ$1.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.32 B-32.61%
2023-12-31NZ$1.96 B3.99%
2022-12-31NZ$1.89 B40.94%
2021-12-31NZ$1.34 B308.28%
2020-12-31NZ$0.32 B67.13%
2019-12-31NZ$0.19 B293.66%
2018-12-31NZ$49.92 M126.03%
2017-12-31NZ$22.08 M22.4%
2016-12-31NZ$18.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$0.83 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$64.78 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.43 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.26 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$54.57 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$0.91 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$63.95 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA